Henry J. Fuchs, President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 2,196 shares at $95.00 ($209K) on 2019-03-04, disclosed to the SEC on 2019-03-06.
Seasonal sale ($209k) by President, Worldwide R&D — this insider has traded BMRN in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |